HIPAA-compliant · Same-day admissions available
Learn how schizophrenia and substance use treatment can address psychosis, addiction, medication needs, family support, and long-term recovery in Knoxville, TN.
New Hope Health
Editorial Team
Schizophrenia is a severe mental illness that can affect thinking, behavior, cognitive functioning, and a person’s ability to manage daily life. For patients with schizophrenia, substance misuse involving alcohol, cannabis, nicotine, or other drugs can create added concerns related to positive and negative symptoms, treatment adherence, physical health, and other co-occurring disorders. Understanding schizophrenia and substance use treatment can help Knoxville families learn what to consider when mental illness and addiction occur together.
Schizophrenia is a severe psychiatric disorder and serious psychiatric illness that affects how a person thinks, feels, behaves, and interprets reality. Common symptoms can include hallucinations, delusions, paranoia, disorganized thinking or speech, reduced motivation, social withdrawal, depression, anxiety, sleep problems, and difficulty with attention or memory, with positive symptoms such as hallucinations and delusions differing from negative and cognitive symptoms. Some people may also experience co-occurring mental health conditions such as major depression, anxiety disorders, PTSD, obsessive-compulsive disorder, substance use disorders, or other mental disorders.
These symptoms can make it harder to maintain relationships, work, attend school, manage daily responsibilities, and live independently. Schizophrenia affects each person differently, and symptoms may change in severity over time. Treatment often includes antipsychotic medication, therapy, family support, and services that address both schizophrenia and co-occurring mental health or substance use conditions.
Schizophrenia and substance use disorders can occur together, and people with schizophrenia face a higher risk of substance-related problems, with patients being five times more likely to have a substance use disorder. Some people may use alcohol or drugs to cope with distress, sleep problems, social isolation, or other symptoms, an idea often described as the self-medication hypothesis.
Shared vulnerability may also reflect environmental factors along with neurobiological influences and inherited susceptibility. One explanation is the diathesis-stress model, which describes how genetic risk can interact with external stressors. When both conditions are present, integrated treatment can address mental health symptoms and substance use at the same time. Reward-related brain mechanisms may also overlap, a pattern sometimes described as reward deficiency syndrome. Brain structure and the brain reward circuit may influence vulnerability to developing substance use disorders in people with schizophrenia.
Common substances include alcohol, with a reported lifetime prevalence of alcohol use disorder in schizophrenia ranging from 21% to 86%, cannabis or marijuana, where heavy use has been associated with a four-fold increase in psychosis risk, nicotine from cigarettes or vaping, stimulants such as cocaine and methamphetamine, and opioids such as heroin, fentanyl, oxycodone, and hydrocodone.
In cannabis users, adolescent exposure has been linked to earlier onset of schizophrenia and may raise the risk of developing schizophrenia later. Misuse of prescription medications, including benzodiazepines such as Xanax or Valium, can also occur. Risk factors include untreated psychiatric symptoms, trauma, chronic stress, social isolation, family history of addiction, easy access to substances, and a history of drug alcohol use.
Alcohol and drug use can worsen hallucinations, delusions, paranoia, disorganized thinking, sleep problems, and changes in mood or behavior. Cannabis and stimulants can be especially concerning because they may trigger or intensify psychotic symptoms in some people, and cannabis-related drug abuse is also associated with developing schizophrenia or psychosis in some people, with cannabis use increasing the risk of psychosis four-fold.
Substance use can also make symptoms less predictable and increase the risk of psychiatric crises or hospitalization.
Substance-induced psychosis involves hallucinations, delusions, or other psychotic symptoms that develop during or soon after substance use, intoxication, or withdrawal. Schizophrenia is a chronic psychiatric disorder in which psychotic and other symptoms are not explained solely by substance use.
Because the conditions can look similar, clinicians review substance use, symptom history, timing, and periods of sobriety before making a diagnosis.
Substance use can interfere with schizophrenia treatment by worsening symptoms, affecting medication adherence, and making it harder to follow a treatment plan. Alcohol and other drugs may also increase sedation or other adverse effects when combined with certain medications. Patients should tell their medical provider about substance use so medications and treatment can be managed safely.
Clinicians may use psychiatric evaluations, medical histories, substance use screenings, physical exams, laboratory tests, and sometimes MRI to rule out other causes of psychosis. They assess the timing of psychotic symptoms and substance use to distinguish schizophrenia, substance-induced conditions, and co-occurring disorders.
Schizophrenia research, including randomized controlled trials and National Institute research, examines clinical characteristics, brain circuits involved in brain reward circuitry, brain-derived neurotrophic factor, assertive community treatment, comorbid schizophrenia, schizoaffective disorder, substance use disorders, and poor physical health.
Substance use disorders are more common among people with schizophrenia than in the general population, and about 47% of schizophrenia patients have substance use disorders. Tobacco use is especially common, with cigarette smoking prevalence often reported in the 60-90% range and reaching about 90% in some groups, while alcohol, cannabis, and other drugs can also contribute to co-occurring addiction.
Prevalence varies by substance, population, and study methods, but the overlap makes routine substance use screening an important part of schizophrenia care.
Integrated dual-diagnosis treatment addresses schizophrenia and a substance use disorder within the same treatment plan. Dual diagnosis patients often face fragmented healthcare services when mental health and addiction care are separated, which is why guidance from the Substance Abuse and mental health services administration is often used to find coordinated care.
It can also address other co-occurring mental health conditions, including depression, anxiety disorders, PTSD, bipolar disorder, and other psychotic disorders. Treatment may combine psychiatric care, addiction counseling, medication management, behavioral therapy, relapse prevention, and family support, including Cognitive Behavioral Therapy (CBT) and motivational interviewing adapted for co-occurring disorders.
Effective programs also often include community-based support to help manage housing, employment, and daily living skills.
Medication management can include pharmacological treatments such as atypical antipsychotics and other second generation antipsychotic medications for schizophrenia, as well as medications for specific substance use disorders when clinically appropriate. In some cases, clozapine treatment may also help reduce substance use in people with schizophrenia. Aripiprazole LAI has also shown benefit for symptom control and substance dependence in some dual-diagnosis cases.
Providers can monitor symptoms, side effects, medication adherence, and possible interactions with alcohol or drugs. Varenicline can also be effective for smoking cessation in schizophrenia. Behavioral therapies can help patients recognize triggers, use motivational strategies to set personal goals and reduce substance use, manage symptoms, and develop coping and relapse prevention skills.
The appropriate level of care depends on psychiatric symptoms, substance use, safety risks, medical needs, and the person’s ability to function independently. Residential treatment provides a structured living environment, while partial hospitalization programs (PHP), intensive outpatient programs (IOP), and standard outpatient care provide different levels of treatment without full-time residential care.
A clinical assessment can help determine the appropriate setting, guided by clinical practice as well as the individual assessment.
Relapse prevention focuses on identifying triggers for substance use and worsening psychiatric symptoms before they lead to a crisis. A long-term recovery plan may include medication management, therapy, peer support, stable routines, family involvement, and continued monitoring of schizophrenia symptoms.
Patients can also develop a plan for responding to cravings, medication problems, or early signs of psychosis.
Families can support recovery by learning about schizophrenia and addiction, encouraging treatment participation, and watching for major changes in symptoms or substance use. Clear communication, healthy boundaries, medication support when appropriate, and a plan for psychiatric or substance-related emergencies can also help.
Families should seek professional guidance rather than trying to manage severe psychosis or addiction alone.
Professional help may be needed when hallucinations, delusions, paranoia, disorganized behavior, substance use, or difficulty functioning begins to interfere with daily life. Emergency help may be necessary if a person is at immediate risk of harming themselves or others, experiences a suspected overdose, or cannot safely care for themselves.
Severe intoxication, withdrawal, or rapidly worsening psychosis can also require urgent evaluation.
Provides structured living and ongoing support for significant mental health and substance use needs.
Partial Hospitalization Program (PHP) provides intensive daytime psychiatric and addiction treatment without overnight residential care.
Intensive Outpatient Program (IOP) provides structured treatment several days per week while allowing greater independence.
Provides scheduled therapy, psychiatric care, and addiction support while patients continue daily responsibilities.
Addresses schizophrenia and substance use disorders within one coordinated treatment plan.
Monitors antipsychotic medications, symptoms, side effects, adherence, and other prescribed medications.
Addresses substance use triggers, coping skills, behaviors, and mental health symptoms.
Provides structured support for recovery skills, substance use, symptom management, and relapse prevention.
Helps families understand symptoms, addiction, boundaries, warning signs, and recovery needs.
Health insurance may cover schizophrenia and substance use treatment when services are medically necessary and included in the plan. Coverage can vary for residential treatment, PHP, IOP, outpatient therapy, psychiatric services, and medications.
Patients should verify benefits, provider networks, deductibles, copays, and prior authorization requirements before beginning treatment.
Schizophrenia and substance abuse can create significant challenges, especially when alcohol use disorder, cannabis use disorder, nicotine dependence, or other mental health disorders occur at the same time. Effective treatments for dual diagnosis patients may include mental health care, substance abuse treatment, behavioral therapy, antipsychotic drugs or other psychotropic drugs, medication management, and continued family support.
Integrated care can address co-occurring schizophrenia and addiction while supporting treatment adherence, symptom management, and better long-term clinical outcomes.
At New Hope Healthcare, as an in-network provider we work with most insurance plans, such as:
If you or a loved one are struggling with mental health challenges or substance abuse, seeking treatment and emotional support is crucial.
Consulting a doctor can provide the necessary support and guidance for your teen. Reach out to New Hope Healthcare today. Our team of compassionate professionals is here to support your journey towards lasting well-being.
Effective medication management is a crucial part of the treatment process to ensure safety and success.
Give us a call at 866-799-0806.
Yes. Integrated dual-diagnosis treatment addresses schizophrenia symptoms and substance use within the same treatment plan.
Yes. Alcohol and drug use can worsen hallucinations, delusions, paranoia, and other symptoms while interfering with treatment.
Treatment may include medication management, behavioral therapy, addiction treatment, family support, and relapse prevention.
Substance use disorders occur more often among people with schizophrenia than in the general population.
Yes. Some substances can cause substance-induced psychosis with symptoms such as hallucinations, delusions, and paranoia.
Families can support treatment, encourage medication adherence, recognize warning signs, reduce substance access, and respond quickly during a crisis.
In This Article
Tags
Learn common suicide warning signs, how families can respond to concerning changes, when urgent help is needed, and what ongoing care support may involve today.
Learn how depression and alcohol treatment can address low mood, drinking, isolation, and daily problems through coordinated mental health and addiction care.
Work can create purpose and stability, but high job demands.
Taking care of a friend or family member can carry an emotional toll.
Leaving a psychiatric hospital can bring relief, uncertainty, and new.
Learn how suicide attempt aftercare supports safety planning, family involvement, dual diagnosis care, and the transition from hospital to outpatient treatment.
New Hope Healthcare Institute offers confidential admissions support for addiction and mental health care—adults and teens—in Knoxville. Call or text 24/7. Verification is not a guarantee of coverage or admission.
